We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » The Night Before Trial, Sun Pharmaceuticals, Owners of Ranbaxy, Settles Multiple Suits for $485M
The Night Before Trial, Sun Pharmaceuticals, Owners of Ranbaxy, Settles Multiple Suits for $485M
Just hours before it was to face the start of a trial, Sun Pharmaceuticals of India said it will pay $485 million to settle years-old lawsuits alleging its Ranbaxy Pharmaceuticals subsidiary falsified data to hoodwink the FDA into granting exclusive approvals for its generic drugs, thus delaying competition and making people pay exorbitant prices for the generics.